Latest Issue

Scientists are developing a new antiviral vaginal gel to reduce HIV infection

The discovery of an antiviral vaginal gel that can reduce HIV infection by around 50 per cent is good news, however qualified. More research is needed: the current clinical trial, in Durban, tested just 889 women. But the virtue of the gel is that it gives some autonomy to women, reducing their chance of contracting the virus when male partners refuse to use a condom.…

Register today to continue reading

You’ve hit your limit of three articles in the last 30 days. To get seven more, simply enter your email address below.

You’ll also receive our free e-book Prospect’s Top Thinkers 2020 and our newsletter with the best new writing on politics, economics, literature and the arts.

Prospect may process your personal information for our legitimate business purposes, to provide you with newsletters, subscription offers and other relevant information.

Click here to learn more about these purposes and how we use your data. You will be able to opt-out of further contact on the next page and in all our communications.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We want to hear what you think about this article. Submit a letter to

More From Prospect